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Purpose: This study aimed to assess alcohol consumption and the occurrence of
alcohol-related seizures in patients with epilepsy within the last 12 months.
Methods: In an epilepsy outpatient clinic, a standardized questionnaire was used
to collect data retrospectively from consecutive adult epilepsy patients who had been
suffering from the disease for at least 1 year. Logistic regression analyses were performed
to identify independent predictors.
Results: A total of 310 patients with epilepsy were included. Of these, 204 subjects
(65.8%) consumed alcohol within the last 12 months. Independent predictors for alcohol
use were antiepileptic drug monotherapy (OR 1.901) and physicians’ advice that a light
alcohol intake is harmless (OR 4.102). Seizure worsening related to alcohol consumption
was reported by 37 of the 204 patients (18.1%) who had used alcohol. All 37 subjects had
consumed large quantities of alcohol prior to the occurrence of alcohol-related seizures
regardless of their usual alcohol-drinking behavior. The amount of alcohol intake prior
to alcohol-related seizures was at least 7 standard drinks, which is equivalent to 1.4 L
of beer or 0.7 L of wine. In 95% of cases, alcohol-related seizures occurred within 12 h
after cessation of alcohol intake. Independent predictors for alcohol-related seizures were
generalized genetic epilepsy (OR 5.792) and chronic heavier alcohol use (OR 8.955).
Conclusions: Two-thirds of interviewed subjects had consumed alcohol within the last
12 months. This finding may be an underestimate due to patients’ self-reporting and
recall error. In all cases, the occurrence of alcohol related-seizures was associated with
timely consumption of considerably large amounts of alcohol. Thus, a responsible alcohol
intake seems to be safe for most patients with epilepsy. However, subjects with epilepsy
and especially those with generalized genetic epilepsy should be made aware of an
increased risk for seizures related to heavy alcohol consumption. Factors accompanying
acute heavy alcohol intake such as altered sleep architecture, impaired adherence to
antiepileptic medication, andmetabolic disturbancesmay further facilitate the occurrence
of seizures.
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INTRODUCTION
Alcohol consumption may trigger seizures in patients with epilepsy. Yet, there is currently little
knowledge on the alcohol-drinking behavior of epilepsy patients. In the 1940s, William G. Lennox
comprehensively analyzed alcohol consumption and the occurrence of alcohol-related seizures in
1,254 subjects with epilepsy (1). However, only about 30% of patients used alcohol, thus excluding
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70% from any analysis of potential alcohol-related effects on the
disease. The occurrence of alcohol-related seizures was reported
by 21.1% of subjects who had used alcohol, and was more
often stated by patients with symptomatic than with idiopathic
or cryptogenic epilepsy (as classified at that time). Apart from
this, there is little research on the occurrence of alcohol-related
seizures in patients with epilepsy. A double-blinded, randomized,
interventional study on 52 subjects with epilepsy demonstrated
that a social alcohol intake over a 4-month-period did not
increase seizure frequencies (2). In another interventional study
on 14 patients with epilepsy and 10 healthy controls, acute
moderate alcohol consumption initially suppressed epileptiform
EEG-activity. Later however, when alcohol blood levels had
declined, epileptiform EEG-activity was increased. Seizures
occurred in some of those subjects and a rebound phenomenon
was discussed (3).
Human and animal data have shown that acute alcohol intake
has a biphasic effect on the central nervous system (CNS).
Initially, the inhibitory gamma-aminobutyric acid (GABA)-ergic
effect of alcohol exerts CNS depressant and anticonvulsant
properties (4, 5). In the post-alcohol state, however, when alcohol
blood levels decline, neuronal excitability is increased which may
facilitate the occurrence of seizures in patients with epilepsy
(6, 7).
The use of alcohol is very common in western societies
(8). In Germany, 89% of all adults had consumed alcohol
within the last 12 months (9). This makes it necessary for
neurologists and other physicians to advise patients with epilepsy
adequately on how to handle alcohol consumption with their
chronic disease. The relationship between alcohol and epileptic
seizures is complex. Research has mainly focused on the
prevalence and pathophysiology of acute symptomatic seizures
in the context of the alcohol withdrawal syndrome in alcohol-
dependent subjects (10–12) and on the risk to develop epilepsy
due to regular alcohol consumption (13, 14). However, there are
only a few studies that have examined the patterns of alcohol
drinking in subjects with a known history of epilepsy, and
these are limited by outdated results or small sample sizes. In
particular, data on seizure worsening associated with alcohol
consumption in patients with epilepsy are very sparse. Therefore,
we aimed (a) to systematically analyze the alcohol-drinking
behavior of patients with epilepsy and (b) to identify independent
predictors for alcohol use and the occurrence of alcohol-related
seizures.
MATERIALS AND METHODS
Data Collection Using a Standardized
Questionnaire, Interview Situations, and
Interview Techniques
Between October 2008 and April 2010, consecutive patients
treated at the Epilepsy Outpatient Clinic, Department of
Neurology, Charité—Universitätsmedizin Berlin were informed
about the study and invited to participate. The data collection on
alcohol use was part of a research project systematically gathering
information on nicotine, alcohol, and illicit drug use in epilepsy
patients within the last 12 months. The data was collected by
a standardized questionnaire (see Supplementary Material). We
have published data on epilepsy and illicit drug use earlier (15).
Only subjects ≥18 years who had suffered from epilepsy for
at least 1 year were included. Epilepsy types and seizures were
classified according to the International League Against Epilepsy
(16). A single unprovoked seizure was defined as epilepsy if
specific EEG alterations or causal brain lesions identified by
magnetic resonance imaging (MRI) indicated an increased and
enduring risk for further epileptic seizures (17). Subjects were
excluded from participation if they had experienced status
epilepticus or acute symptomatic seizures exclusively, if they had
a history of psychogenic non-epileptic seizures, or if cognitive
deficits, mental retardation or German language barrier impeded
adequate understanding and reply to the questions. Patients with
legal representatives were also not enrolled.
Prior to the interview, each participant was educated on the
scientific background and purpose of the study. We placed great
importance on a relaxed and informal interview atmosphere,
and each subject was thoroughly informed that all moral
aspects regarding nicotine, alcohol, and illicit drug use were
irrelevant and that all data would be made anonymous and
remain confidential. Thereby, we attempted to increase subjects’
receptivity to the questions and avoid patients answering the
questions in a more socially acceptable way. In several test-
interviews, patients were intimidated when being asked about
nicotine, alcohol, and illicit drug intake in front of their
companions. Therefore, all interviews were held in a separate
study room where only the interviewer and the patient were
present. To ensure a standard and informal interview situation
all patients were interviewed by the same person (MiHa) who
was not one of the treating physicians at the Epilepsy Outpatient
Clinic.
Alcohol consumption usually represents a taboo in the doctor-
patient relationship and questions on the smoking status are
answered more easily. Therefore, subjects were first queried
about nicotine consumption and only later asked to give details
on alcohol use. Toward the end of the interview, patients were
questioned on illicit drugs. Study subjects passed through the
domains of the questionnaire with an increasing social stigma
degree.
In the opening question on alcohol use, subjects were asked:
“Do you have any experience with alcohol consumption?” For
this question, patients were able to respond in their own words
and did not have to choose a predetermined response option. The
interviewer carefully noted the given information on the quantity
and frequency of alcohol consumption in the opening question.
Subjects who had consumed alcohol within the last 12 months
stated details on alcohol intake in the opening question and
later by specifying the quantity and frequency of their individual
alcohol consumption. Using that approach, the reliability of
patients’ responses on alcohol use could be evaluated regarding
consistency. Data were excluded, if the patients’ responses were
inconsistent, if subjects were too hesitant to answer the questions,
or if patients had refused to give details in only one of the
interview’s topics, that is nicotine, alcohol drinking and illicit
drug use.
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FIGURE 1 | Amounts of different alcoholic beverages that correspond to 1
standard drink as defined by the World Health Organization. This illustration
has been shown to the participants of this study to guide them in estimating
their individual average alcohol intake per drinking occasion.
To ensure a comparable evaluation, alcohol consumption
was translated and expressed in standard drinks containing
10 g of pure alcohol (18). To assist subjects in measuring their
individual average alcohol intake per drinking occasion, a chart
illustrating different alcoholic beverages containing a single
standard drink was shown to each study participant (Figure 1).
Regarding the usual frequency of alcohol consumption within
the last 12 months, subjects were able to choose one out of the
following different categories: daily, almost daily, 1–2 times a
week, 1–2 times a month or <1–2 times per month. According
to that, patients who had consumed alcohol within the last 12
months were summarized in the following three alcohol drinking
categories: Patients with alcohol intake of no more than 3–4
standard drinks daily, almost daily, 1–2 times per week or less
than weekly were considered as light or occasional alcohol users.
Moderate alcohol users were subjects who consumed more than
occasional or light users but not more than 5–6 standard drinks
daily, almost daily and not more than 9–10 standard drinks
1–2 times per week. Heavier alcohol use was considered as
alcohol intake of more than 5–6 standard drinks daily, almost
daily or more than 9–10 standard drinks 1–2 times per week.
Alcohol abstinence was defined according to the World Health
Organization (WHO) as a period of at least 12 months of non-
consumption1.
The Alcohol Use Disorder Identification Test (AUDIT) is a
10-item core questionnaire developed by the WHO to identify
hazardous and harmful alcohol intake (18) (Supplementary
Material: questions 32–41), and was applied in all subjects who
had consumed alcohol within the last 12months. Patients are able
to score up to a total of 40 points in domains like harmful alcohol
intake and dependency symptoms. We considered patients as
AUDIT-positive with AUDIT scores ≥8. This cut-off has been
found to provide an accurate measure of harmful alcohol
drinking across age, gender, and cultures (19).
Apart from that, all interviewed subjects were asked what their
trusted neurologist or physician had told them regarding alcohol
consumption in the context of their epilepsy. Patients were able
1Lexicon of Alcohol and Drug Terms. WHO. Available online at: http://www.who.
int/substance_abuse/terminology/who_lexicon/en/
to choose one out of four response options: (a) alcohol should
be avoided completely, (b) alcohol can be consumed without any
restriction, (c) light alcohol intake is harmless, or (d) no advice
given by the physician.
Alcohol-Related Seizures
In this study, an alcohol-related seizure was defined as a seizure
in the context of epilepsy that occurred within short temporal
relation to alcohol use (<24 h). Alcohol users were asked “Do
you have experienced an alcohol-related seizure within the last 12
months?” If patients had experienced an alcohol-related seizure
in the last 12 months, they were requested to recall details on the
quantity of alcohol intake prior to the seizure and on the time
between cessation of alcohol intake and seizure manifestation
(<6 h/≥6–<12 h/≥12–<24 h). The quantity of alcohol intake
again was calculated and expressed in standard drinks to ensure
a comparable evaluation (Figure 1). If patients had experienced
more than one seizure related to alcohol use within the last 12
months, they were asked to state details on the seizure occurrence
they remembered the best.
Statistical Analysis
Continuous data are presented as mean ± standard deviation
(SD) or median where appropriate. Logistic regression analyses
were used to calculate odds ratios with 95% confidence intervals
as estimates for variables independently predicting alcohol use
and the occurrence of alcohol-related seizures within the last 12
months.
In the logistic regression models, clinical data on patients’ sex,
age at interview, duration of epilepsy, epilepsy type, antiepileptic
drug therapy, seizure frequency, alcohol drinking behavior over
the last 12 months, and physicians’ advice on alcohol use were
included as possible confounding variables. In the results section
of logistic regression analyses, findings were only noted if 95%
CIs of the confounding variable did not include 1; if the 95% CI
included 1, the corresponding variable was not significant and
therefore was not pointed out. Statistical analyses were calculated
using IBM SPSS statistics 24.0.
RESULTS
Study Population
The study population consisted of 310 patients with epilepsy
(Table 1). Of these, seven subjects had suffered from only one
single unprovoked seizure: In four of these patients remote
structural brain lesions were demonstrated by neuroimaging
indicating focal epilepsy. In one patient, interictal EEG findings
were consistent with generalized genetic epilepsy, and in two
subjects, EEG showed regional spikes and sharp waves without
MRI structural brain lesions indicating focal epilepsy of unknown
origin.
Alcohol Consumption
Out of 310 interviewed subjects, 204 (65.8%) had used alcohol
within the last 12 months, 158 (51%) within the last 30
days, and 108 (34.8%) within the last 7 days. Antiepileptic
drug monotherapy (OR 1.901) and physicians’ advice that a
light alcohol intake is harmless (OR 4.102) were independent
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TABLE 1 | Characteristics of the study population (n = 310).
Variable No. (%)/mean ± SDa
Sex Female 171 (55.2)
Male 139 (44.8)




Epilepsy type Focal 213 (68.7)
GGEb 67 (21.6)
Unknown 30 (9.7)
AEDc Monotherapy 184 (59.4)
Polytherapy 121 (39.0)
No treatment 5 (1.6)
Seizure frequency ≥1/month 130 (41.9)
<1/month 180 (58.1)
Alcohol use in the
last 12 months
Alcohol abstinence 106 (34.2)
Occasional or light use 147 (47.4)
Moderate use 43 (13.9)
Heavier use 14 (4.5)
Physicians’ advice
on the use of
alcohol
Alcohol should be avoided
completely
127 (41.0)
No advice given 94 (30.3)
Alcohol can be consumed
without restriction
2 (0.6)
Light alcohol intake is harmless 87 (28.1)
aSD, standard deviation.
bGGE, generalized genetic epilepsy.
cAED, antiepileptic drug.
predictors for alcohol use within the last 12 months (Tables 2, 3).
Out of the 204 patients who used alcohol, 147 (72%) were
occasional or light alcohol users, 43 (21.1%) were moderate
users and 14 subjects (6.9%) practiced heavier alcohol use. Nine
subjects of the study population (2.9%) were AUDIT positive
indicating hazardous and harmful alcohol use. All AUDIT
positive subjects were heavier alcohol users.
Ninety-five patients (30.7%) were alcohol-experienced but
had been abstinent in the last year. Eleven subjects 11 (3.5%) had
never tried alcohol in their lifetime.
In alcohol-experienced subjects, who abstained from alcohol
within the last 12 months (n = 95), epilepsy was reported to
be the most common reason for no longer drinking alcohol
(n = 50; 52.6%). Of those 50 patients, 49 subjects stated that
they would consume alcohol if epilepsy had not been diagnosed
and 16 patients stated that alcohol abstinence due to epilepsy is a
challenge.
Alcohol-Related Seizures
Thirty-seven out of 204 alcohol users (18.1%) had experienced
alcohol-related seizures within the last 12 months (Table 4). In
95% (n = 35) of cases, these seizures had occurred within 12 h
after cessation of alcohol intake.
In multivariate analysis, subjects with heavier alcohol use in
the last 12 months were more likely to experience alcohol-related
seizures (OR 8.955), whereas occasional or light and moderate
alcohol use was not associated with increased risk for alcohol-
related seizures (Tables 5, 6). However, most of the patients
(78.4%) who reported alcohol-related seizures were occasional,
light or moderate alcohol users who had changed their usual
alcohol intake toward higher consumption on the drinking
occasion prior to the seizures (Table 4). The amount of alcohol
intake before the occurrence of alcohol-related seizures was very
high in all of the cases with a mean of 13.3± 5.8 standard drinks
(median 12.5, range 7–34), which is equivalent to 2.5 L of beer or
1.25 L of wine. The minimum was 7 standard drinks, equivalent
to∼1.4 L of beer or 0.7 L of wine.
Patients with generalized genetic epilepsy (OR 5.792) were
more likely to experience alcohol-related seizures compared to
patients with focal epilepsy (Tables 5, 6). In patients with focal
epilepsy, the mean amount of alcohol intake prior to alcohol-
related seizures was 14.4 ± 6.5 (median 13, range 7.5–34)
standard drinks, and in subjects with generalized genetic epilepsy
12.3 ± 5.9 (median 11.3, range 7–30). No significant difference
was detected (p= 0.366).
In female patients, the mean amount of alcohol intake before
alcohol-related seizures was 10.9 ± 3.1 standard drinks (median
11.3, range 7–15), and in male subjects, 15.4 ± 6.8 (median 15,
range 7.5–34; p= 0.02).
Fifteen out of 95 (15.8%) alcohol-experienced but now
abstinent subjects had experienced alcohol-related seizures in the
past. In that group, the mean amount of alcohol intake prior
to the seizures was 10.9 standard drinks. All of these patients
stated that they had stopped alcohol consumption because of the
experience of alcohol-related seizures.
DISCUSSION
In this study, we aimed to systematically analyze alcohol drinking
and the occurrence of alcohol-related seizures in 310 epilepsy
patients. Even though alcohol use may trigger seizures, 65%
of interviewed subjects had consumed alcohol within the last
12 months and every third patient had consumed alcohol
within the last 7 days. Our results are in line with previous
population-based study findings from Canada reporting a 12-
month prevalence of alcohol use in patients with epilepsy of
57.6% (20). In our study, most subjects were occasional or light
alcohol users. Regarding chronic heavy alcohol consumption, our
cohort of patients had used alcohol far more responsibly than the
general adult German population. Only 2.9% of our interviewed
study subjects were AUDIT positive indicating hazardous and
harmful alcohol intake. By contrast, data from the general adult
German population showed that a proportion of 19.7% is AUDIT
positive (9).
In multivariate analysis, alcohol consumption within the last
12 months was independently related to AED monotherapy. It
is highly likely that subjects with well-controlled epilepsies on
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TABLE 2 | Possible confounding variables that were included in the logistic regression model regarding alcohol consumption within the last 12 months.
Variable Alcohol use within the last 12 months (n = 204) Alcohol-abstinence (n = 106)
No. (%)/mean ± SDa No. (%)/mean ± SD
Sex Female 108 (52.9) 63 (59.4)
Male 96 (47.1) 43(40.6)
Age (in years) 43.8 ± 15.9 46.3 ± 16.7
Duration of epilepsy (in years) 18.9 ± 15.8 22.5 ± 18.4
Epilepsy type Focal 135 (66.2) 78 (73.6)
GGEb 45 (22.1) 22 (20.8)
Unknown 24 (11.7) 6 (5.6)
AEDc Monotherapy 130 (63.7) 54 (50.9)
Polytherapy 69 (33.8) 52 (49.1)
No treatment 5 (2.5) 0
Seizure frequency ≥1/month 76 (37.3) 54 (50.9)
<1/month 128 (62.7) 52 (49.1)
Physicians’ advice Alcohol should be avoided completely 73 (35.8) 54 (51)
No advice 56 (27.4) 38 (35.8)
Alcohol can be consumed without restriction 2 (1) 0
Light alcohol intake is harmless 73 (35.8) 14 (13.2)
aSD, standard deviation.
bGGE, generalized genetic epilepsy.
cAED, antiepileptic drug treatment.
TABLE 3 | Independent predictors for alcohol consumption within the last 12
months.
Variable ORa 95% CIb P-value
AEDc Polytherapy 1.0 (ref.)
Monotherapy 1.901 1.152–3.138 p = 0.012










No advice 1.043 0.599–1.814 p = 0.883
Light alcohol intake is
harmless
4.102 2.078–8.097 p < 0.0001
aOR, odds ratio.
bCI, confidence interval.
cAED, antiepileptic drug treatment.
dN/A, not available.
monotherapy are more likely to consume alcoholic beverages
than those with difficult-to-treat variants. Physicians’ advice that
“a light alcohol intake is harmless” was identified as an additional
predictor for alcohol use. Patients with epilepsy may feel unsure
about alcohol consumption on chronic medication and therefore
may be willing to follow physicians’ advices more often.
Thirty-seven out of 204 epilepsy patients who had consumed
alcohol remembered that they had experienced an alcohol-related
seizure within the last 12 months. These seizures occurred in
the timely context of acute heavy alcohol consumption. The
occurrence of seizures in short temporal relation to alcohol
consumption may not prove that these seizures were necessarily
causally related to alcohol use. The following arguments however
support this hypothesis: Most subjects with alcohol-related
seizures were occasional, light or moderate alcohol users but
a noticeable change in their usual alcohol-drinking behavior
toward higher consumption prior to the seizures could be
documented. This taken together with the fact that almost all
alcohol-related seizures (95%) had occurred within the first 12 h
after cessation of alcohol intake support a causal relationship
between alcohol use and temporally close seizure manifestation
in these cases.
In the study population, generalized genetic epilepsy was
an independent predictor for the occurrence of alcohol-related
seizures. The mean alcohol intake prior to alcohol-related
seizures was not higher in patients with generalized genetic
epilepsy than in subjects with focal epilepsy. Lennox stated that
alcohol-related seizures had occurred more often in patients with
symptomatic than in cryptogenic or idiopathic epilepsies (1).
The then applied syndromatic allocation, however, may not be
in exact conformance with the present classifications (16, 17).
Janz (21) later observed that alcohol-related seizures were more
likely to occur in subjects with generalized genetic epilepsy
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TABLE 4 | Clinical variables of patients with epilepsy who had experienced alcohol-related seizures within the last 12 months (n = 37).
Patient-ID Alcohol intake prior to alcohol-related
seizures (standard drinks)
Time between cessation of alcohol
intake and seizure occurrence (range
in hours)
Usual alcohol-drinking behavior within
the last 12 months
Epilepsy type
#17 15 ≥12–<24 Occasional or light use Unknown
#25 8.75 <6 Occasional or light use GGE a
#31 15 ≥6–<12 Occasional or light use Focal
#32 10 ≥6–<12 Occasional or light use Focal
#38 34 <6 Heavier use Focal
#40 7 ≥6–<12 Moderate use GGE
#53 12 <6 Occasional or light use Focal
#54 17.5 <6 Occasional or light use Focal
#63 15 ≥6–<12 Occasional or light use GGE
#65 12.5 ≥6–<12 Moderate use GGE
#77 7.5 <6 Occasional or light use GGE
#81 20 <6 Heavier use GGE
#83 7.5 ≥6–<12 Heavier use GGE
#87 12 <6 Moderate use GGE
#116 7.5 <6 Occasional or light use Focal
#133 Not remembered <6 Heavier use Focal
#140 12.5 <6 Moderate use GGE
#141 Not remembered ≥6–<12 Heavier use Focal
#144 12.5 ≥6–<12 Occasional or light use Focal
#147 15 <6 Occasional or light use Focal
#154 10 ≥12–<24 Moderate use Focal
#178 15 <6 Occasional or light use Unknown
#185 15 <6 Heavier use Unknown
#188 14.5 <6 Occasional or light use Focal
#199 11.5 <6 Occasional or light use Focal
#223 Not remembered <6 Heavier use GGE
#258 15 <6 Moderate use GGE
#264 7.5 <6 Occasional or light use GGE
#272 15 <6 Occasional or light use Unknown
#274 30 <6 Occasional or light use GGE
#276 10.5 ≥6–<12 Occasional or light use GGE
#278 12.5 <6 Occasional or light use GGE
#280 13 ≥6–<12 Occasional or light use Focal
#282 7.5 ≥6–<12 Occasional or light use Unknown
#283 10 <6 Occasional or light use GGE
#291 8.75 <6 Moderate use GGE
#308 15 ≥6–<12 Heavier use Focal
aGGE, generalized genetic epilepsy.
than in those with focal epilepsy, which is consistent with our
findings (21).
Acute alcohol consumption suppresses central nervous
excitability by activating the inhibitory GABA-system (22).
GABA is the major inhibitory neurotransmitter in the brain.
Furthermore, alcohol inhibits glutamate activity, which is the
major excitatory neurotransmitter of the CNS. Thus in subjects
with epilepsy, alcohol intake initially reduces CNS epileptiform
EEG-activity. Later however, when alcohol blood levels decline,
epileptiform EEG-activity has been shown to be increased which
is associated with a higher risk for seizures (4–6, 23). In
an experimental study on mice with chronic epilepsy, seizure
thresholds were measured after the administration of ethanol.
Initially, anticonvulsant properties of ethanol were observed,
but later a transient lowering of seizure thresholds and hyper-
susceptibility to seizures were reported (7).
In patients with generalized genetic epilepsy, seizures
commonly manifest within 30min after awakening. A
transcranial magnetic stimulation study on patients with
genetic generalized epilepsy demonstrated that motor cortex
excitability was significantly increased in the early morning
(24). In subjects with generalized genetic epilepsy, this increased
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TABLE 5 | Possible confounding variables that were included in the logistic regression model regarding the occurrence of alcohol-related seizures in patients with epilepsy
within the last 12 months.
Variable Alcohol-related seizure occurrence
within the last 12 months (n = 37)
No alcohol-related seizures within the
last 12 months (n = 167)
No. (%)/mean ± SDa No. (%)/mean ± SD
Sex Female 17 (45.9) 91 (54.5)
Male 20 (54.1) 76 (45.5)
Age (in years) 40.7 ± 14.7 44.5 ± 16.1
Duration of epilepsy (in years) 20.3 ± 15.1 18.6 ± 16
Epilepsy type Focal 15 (40.6) 120 (71.9)
GGEb 17 (45.9) 28 (16.8)
Unknown 5 (13.5) 19 (11.3)
AEDc Monotherapy 22 (59.5) 108 (64.7)
Polytherapy 14 (37.8) 55 (32.9)
No treatment 1 (2.7) 4 (2.4)
Seizure frequency ≥1/month 13 (35.1) 63 (37.7)
<1/month 24 (64.9) 104 (62.3)
Alcohol use within the last 12 months Occasional or light use 22 (59.5) 125 (74.8)
Moderate use 7 (18.9) 36 (21.6)
Heavier use 8 (21.6) 6 (3.6)
aSD, standard deviation.
bGGE, generalized genetic epilepsy.
cAED, antiepileptic drug.
TABLE 6 | Independent predictors for the occurrence of alcohol-related seizures
within the last 12 months in patients with epilepsy.
Variable ORa 95% CIb P-value
Epilepsy type Focal 1.0 (ref.)
GGEc 5.792 2.427–13.823 p < 0.0001
Unknown 2.185 0.664–7.189 p = 0.198
Alcohol use within




Moderate use 0.819 0.306–2.194 p = 0.691
Heavier use 8.955 2.625–30.545 p < 0.0001
aOR, odds ratio.
bCI, confidence interval.
cGGE, generalized genetic epilepsy.
neuronal excitability in the early morning may be potentiated
by the hyper-excitable post-alcohol state, and this effect may be
responsible for the increased susceptibility to alcohol-related
seizures compared to focal epilepsy.
Clinical Perspective
Most of our interviewed subjects (>80%) that consumed alcohol
within the last 12 months did not experience alcohol-related
seizures. Current data on the quantity of alcohol intake prior
to the occurrence of alcohol-related seizures in patients with
epilepsy highly suggest that these situations are related to the
acute consumption of considerably large amounts of alcohol.
Subjects who reported alcohol-related seizures had consumed
at least 7 standard drinks before seizures occurred which is
equivalent to 1.4 L of beer or 0.7 L of wine. Occasional or
light and moderate alcohol-drinking behavior was not associated
with alcohol-related seizure occurrences. In the general German
population, 89% of all adults had used alcohol within the last
12 months, only 8% were alcohol-experienced but abstinent,
and 3% had never used alcohol in their lifetime (9). In the
present study, 30.7% of patients were alcohol-experienced but
abstinent and 3.5% had never consumed alcohol in their lifetime.
Therefore, the proportion of alcohol-experienced but abstinent
subjects with epilepsy was almost four times higher than in
the general population. Epilepsy was often stated to be the
only reason for alcohol-abstinence, which felt challenging to
many subjects. Alcohol abstinence may not be necessary as
long as epilepsy patients practice a responsible alcohol intake.
Subjects with generalized genetic epilepsy however should be
made aware of their increased susceptibility to alcohol-related
seizures.
Limitations
Our systematic data collection based on personal interviews
allowed us to provide updated knowledge on the patterns of
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alcohol drinking and the occurrence of alcohol-related seizures
in a large cohort of 310 epilepsy patients.
Several limitations have to be discussed. First, our data on
alcohol use depended on patients’ self-reporting and may be
affected by recall bias. It has been demonstrated that assessing
alcohol consumption is biased by recall even when the recall
period is only 1 week (25). In our study population, alcohol
consumption is probably underestimated. However, this does
not impact our main findings. Moreover, patients were seen
at our institution at scheduled outpatient visits and did not
attend the clinic after acute manifestations of alcohol-related
seizures. Only a minority of patients documented details on
alcohol-related seizures in seizure diaries. Our retrospective data
collection on alcohol-related seizures also depended on subjects’
recall capability, and may reflect bias due to recall errors. We
addressed this by focusing only on alcohol-related seizures that
had occurred within the last 12 months. Details were only
recorded on those alcohol-related seizures that subjects were able
to remember the best. As a consequence however, alcohol-related
seizures may have also occurred after smaller amounts of alcohol
intake or in other circumstances that were not taken into account
in the present study.
Second, as patients were interviewed retrospectively on the
occurrence of alcohol-related seizures, we were not able to
provide data on AED drug levels after the acute manifestation of
these seizures. We cannot exclude that subjects might have been
more prone to seizure occurrences due to AED non-adherence.
Furthermore, we cannot exclude hypoglycemic episodes caused
by acute heavy alcohol consumption (26), which may have
contributed to the manifestation of epileptic seizures (27).
Third, other studies have shown that alcohol consumption
and especially the consumption of considerable large amounts
of alcohol may reduce sleep quality by increasing light sleep and
wake-up periods during the second half of the night time sleep
period (28, 29). In addition to that, alcohol intake significantly
suppresses REM sleep periods (30). Reduced sleep quality and
consecutive sleep deprivation have long been discussed to
facilitate the occurrence of seizures in patients with epilepsy (31),
and especially in those with generalized genetic epilepsy (32–
34). Altered sleep architecture due to acute alcohol consumption
constitutes a non-negligible and important co-factor for seizure
risk in patients with epilepsy. Due to the retrospective design of
the present study, we were not able to assess sleep quality prior to
alcohol-related seizure occurrences. Future prospective research,
e.g., using polysomnography, will be needed to provide insight
into the complex relationship between alcohol consumption,
altered sleep architecture and timely manifestation of seizures.
Finally, the present study population was exclusively recruited
at a tertiary care epilepsy center where usually patients with
more severe variants of the disease are treated. This indicates a
potential selection bias and our results may not be generalized to
all epilepsy patients without restrictions.
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